February 2018 Issue

GO TO FULL ISSUE

Med Updates

Ozempic
semaglutide
A GLP-1 agonist for type 2 diabetes

Siliq
brodalumab
An IL-17RA antagonist for moderate to severe plaque psoriasis

Juluca
dolutegravir/rilpivirine
New combination formulation for HIV-1 infection

MORE MED UPDATES